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 Summary
  The aim of this work is to study the usage of multi-detector HRCT chest in diagnosing pulmonary 
TB cases whose sputum smears are negative and making a correlation between their CT features 
and their sputum culture results.
  This study was carried out from December 2014 to December 2016 at Zagazig university hospitals, 
Radiodiagnosis department. It included 150 patients. Their ages ranged between 10 to 70 years 
with a mean age 40 years. They were referred from the outpatient respiratory medicine clinic 
of the hospital. All patients had been presented clinically with suspicion of PTB. Their clinical 
features and HRCT findings were investigated to predict the risk for PTB. We then designed 
provisional HRCT diagnostic criteria based on the results to rank the risk of PTB.
  A positive tuberculin skin test alone among clinical laboratory findings was significantly associated 
with an increase of risk of PTB. Centrilobular nodules, large nodules, tree-in-bud appearance 
and the main lesion being located in S1, S2, and S6 lung segments were significantly associated 
with an increased risk of PTB. At HRCT 40 out of 44 patients with class III ranking showed active 
pulmonary TB. 12 out of 51 patients presented with class II ranking and 8 out of 40 were ranked 
as class I. The sensitivity, specificity and positive likelihood ratio of class I ranking HRCT criteria 
to diagnose active pulmonary TB were 95%, 40% and 1.4, respectively. Class II ranking results were 
85%, 72%, 3, respectively. Finally class III ranking results were 45%, 90%, 11.5, respectively.
  Cases suspected of having active pulmonary TB whose smears are negative can benefit from MD 
HRCT chest findings to predict those patients of high risk with good reproducibility.
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Tuberculosis (TB) is one of the infectious disease world-
wide, being one of the commonest causes of death, after 
Human Immunodeficiency Virus (HIV) infection, with an 
estimated 8.7 million new cases of TB in 2011 [1].
Nearly one-half to one-third of the pulmonary tuberculo-
sis (PTB) cases are smear-negative and approximately 1.9 
million new PTB cases were found to be smear-negative in 
2011 [2].
The sensitivity of sputum smear examination for acid-fast 
bacilli (AFB) is poor, therefore, rapid and accurate diagnosis 
of smear negative pulmonary tuberculosis (TB) is warrant-
ed. A high probability of PTB needs to be identified among 
sputum smear-negative findings without missing patients 
who do indeed have PTB [3]. A significant proportion of the 
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patients treated for smear negative PTB never have bacte-
riological confirmation, even with improved culture meth-
ods, therefore, most cases of smear-negative PTB are diag-
nosed on the basis of the clinical presentation, radiological 
findings and other laboratory tests [1].
In cases of PTB, the presence of cavities and satellite 
lesions detected at computed tomography (CT) scans and 
cannot be detected at chest X-ray, can provide more accu-
rate information about the extent and distribution of the 
disease process. Furthermore, CT can distinguish cases 
with active from old infection process [4].
It had been shown that presence of cavities and airspace 
consolidation could be related to the degree of positivity in 
PTB patients’ smears. There are some pieces of data about 
the relationship between morphologic findings on high-res-
olution computed tomography (HRCT) and the number of 
AFB on sputum smears in patients with PTB [5,6].
The aim of this work is to study the usage of multi-detector 
HRCT chest in diagnosing pulmonary TB cases whose spu-
tum smears are negative and making a correlation between 
their CT features and their sputum culture results.
Material and Methods
Patients
A total of 150 Egyptian patients were included in the study, 
that had been conducted from December 2014 to December 
2016 at multidetector CT unit, Zagazig University hospitals.
Patients were referred from the respiratory medicine out-
patient clinic, Zagazig University hospital. Their ages range 
from 10 to 70 years old with a mean of 40 years.
Patients included are those with high suspicion of having 
active pulmonary TB (By clinical examination and X ray 
findings) and showing smear negative for acid-fast bacilli 
(AFB) in three consecutive sputum samples.
Those having positive AFB in their sputum smears were 
excluded. HIV or immune-compromised patients were 
not included in this study as well. Those with atypical 
MD-HRCT findings for PTB were followed up clinically and 
even biopsied.
All participants signed a written informed consent and 
filled a written survey including demographic and clinical 
data. The protocol and informed consent forms used in this 
study were approved by the Institutional Review Board 
(IRB) of Zagazig University.
Methods
All patients were subjected to:
1.  History taking: must exclude any chronic chest disease, 
old TB and those taking anti-tuberculous treatments.
2.  Symptom analysis: any symptoms of pulmonary TB 
such as: cough, hemoptysis, loss of weight, fever or night 
sweating.
3. Clinical examination.
4. Tuberculin skin test.
5.  Bacteriologic analysis: Three successive sputum sam-
ples for three successive days were collected in the early 
morning for detection of AFB. If the process of sponta-
neously giving sputum by the patient not possible, we 
used hypertonic saline nebulizer in the early morning 
preceded by salbutamol inhalation for induction of spu-
tum. Direct smear examination of the samples were done 
after that using Zeihl-Neelsen stain. Culturing for myco-
bacterial tuberculosis was done using Lowenstein Jensen 
media. Finally the samples were incubated for 8 weeks 
before the final results collected.
6.  HRCT chest: Through 128-row multidetector CT scan-
ner (PHLIPS Ingenuity Core 128 TM, Philips Healthcare 
Nederland B.V., Veenpluis 4–6, 5684 PC Best, The 
Netherlands), the chest MDCT studies were performed 
utilizing 1.25 mm slice thickness, 120: 140 kV, 400: 600 
mAs, 512×512 matrix size. Examination was done while 
the patient is lying supine during single breath-hold in a 
cranial-to-caudal direction. Using high spatial resolution 
algorithm [7], series of contiguous thin-collimation 1.25 
mm axial high resolution images were reconstructed 
from the volumetric data set. Images were analyzed in 
both pulmonary and mediastinal window.
Image analysis
Obtained images were assessed for the existence of centri-
lobular nodules, tree in bud pattern (indicate endobronchial 
spread of infection), larger nodules, masses, lobular consol-
idations, cavities, bronchoceles, ground glass opacities and 
mediastinal lymph node enlargement (Table 1). The distri-
bution of findings was assessed for the presence of a main 
lesion in lung segments namely S1, S2 and S6.
To predict the risk for active pulmonary TB, we applied the 
criteria designed by Nakanishi et al., [3] that were based 
on the combination of HRCT findings, subsequently the 
MD- HRCT findings Number of cases (%)
Centri-lobular nodules  135 (90%)
Large nodules  90 (60%)
Tree-in-bud  50 (33.33%)
Peribronchial thickening  29 (19.33%)
Traction bronchiectasis  24 (16%)
Lymph node enlargement  23 (15.33%)
Consolidation  20 (13.33%)
Calcified granuloma  19 (12.66%)
Ground glass opacity  17 (11.33%)
Cavity  12 (8%)
Mass  10 (6.66%)
Emphysema  5 (3.33%)
Table 1.  MD-HRCT findings in patients with sputum negative 
pulmonary TB.
NB – More than one finding could be seen in the same patient.
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patients were ranked from 0 to 3 (Table 2). Two radiologists 
record each HRCT finding and decide the rank.
Statistical analysis
Data collected was revised, coded, tabulated and intro-
duced to personal computer for statistical analysis. All data 
manipulation and analysis were performed using the 20th 
version of SPSS (Statistical Package for Social Sciences). We 
applied stepwise regression, to determine the HRCT find-
ings that had significant association with increased risk 
of pulmonary TB. Analysis of inter-observer variation for 
every finding was done using Kappa test (the k statistics). 
Using a weighted k statistics, the interobserver variation in 
the ranking process for every patient was examined.
Results
The mean age of the patients was 40 years. Age group 
between 30 and 40 years was the chiefly affected group 
(Table 3). Predominance of male gender (70% of the 
patients) was noticed. Cough was the commonest symptom, 
presented in 90% of the patients, followed by chest pain 
in 66%, expectoration in 53%, hemoptysis in 30%, fever in 
13%, weight loss in 8%, night sweating in 6% and dyspnea 
in 4% of the patients (Table 4).
The final diagnosis of pulmonary TB at that work was 
dependent on AFB culture results which considered a gold 
standard for diagnosing pulmonary tuberculosis.
The commonest HRCT findings were centrilobular nodules 
(90%), large nodules (60%) and tree in bud appearance (33%). 
The complete radiological findings are presented in Table 1.
Rank number Description HRCT findings required for diagnosis
3 (III) Highly suspect pulmonary TB (PTB) Presence of at least three of the following findings: 
1.Main lesion in S1, S2 or S6 segments.
2.Tree in bud appearance.
3.Lobular consolidations.
4.Larger nodules.
2 (II) Probable pulmonary TB (PTB) Presence of at least two of the following findings: 
1.Main lesion in S1, S2 or S6 segments.
2.Tree in bud appearance.
3.Lobular consolidations.
4.Larger nodules.
1 (I) Non-specific or difficult to differentiate from other disease Lesions located mainly in the middle lobe or lingular segment.
0 Other suspected disease Findings indicative of other specific disease.
Table 2. Ranking of patients according to MD-HRCT findings.
Age Male Female Total
10: <20 years 6 2 8
20: <30 years 14 7 21
30: <40 years 44 21 65
40: <50 years 20 10 30
50: <60 years 15 2 17
60: 70 years 6 3 9
Total (No, %) 105 (70%) 45 (30%) 150 (100%)
Table 3. Demographic data of our patients.
The presenting symptom Number of cases (%)
Cough  136 (90.66%)
Chest pain  100 (66.66%)
Expectoration  80 (53.33%)
Hemoptysis  45 (30%)
Fever  20 (13.33%)
Weight loss  12 (8%)
Night sweating  9 (6%)
Dyspnea  6 (4%)
Table 4. The presenting symptoms of our patients.
NB – More than one symptom could be present in the same patient.
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The localization of the radiological lesions was also evalu-
ated. Radiological lesions were observed in the right (60%) 
and left (20%) upper lobes most frequently (Table 5).
Based on the ranking obtained by CT features, patients 
were divided into three groups: 
1.  Rank I: At HRCT only eight out of the 40 patients ranked 
as I had final diagnosis of active pulmonary TB while in 
the remaining patients five had non-tuberculous myco-
bacterium infection (NTM), 11 had bronchopneumo-
nia, three had cryptogenic organizing pneumonia (COP) 
and two had allergic broncho-pulmonary aspergillosis 
(ABPA).
2.  Rank II: Only 12 out of the 51 patients who were ranked 
as II had final diagnosis of active pulmonary TB, NTM 
were found in six patients, bronchopneumonia in seven 
patients, COP in six patients and ABPA in four patients.
3.  Rank III: 40 out of 44 patients were ranked as III had 
final diagnosis of active pulmonary TB. NTM were found 
in two patients. One of the patients had final diagnosis of 
bronchopneumonia (Table 6).
4.  Calculating the sensitivity, specificity and positive like-
lihood ratio of the different class ranking using HRCT 
criteria for diagnosing active pulmonary TB were as fol-
low: Rank III was 45%, 90% and 11.5, respectively, while 
in rank II it was 85%, 72%, 3, respectively and in rank I 
it was 95%, 40%, 1.4, respectively (Table 7). Figures 1–5 
demonstrate some of the MD-HRCT features in Rank III 
patients.
Discussion
Pulmonary TB can mimic a lot of diseases in clinical and lab-
oratory findings, reliability on sputum smear has many limi-
tations as sputum may be false negative if the disease is mild, 
decreased load of bacilli in the sputum sample and patient 
is giving saliva instead of sputum. The sputum culture take 
several weeks for diagnosis of PTB. Patients with suspected 




Rank 0 Rank I Rank II Rank III
Pulmonary TB 0 8 12 40 60
NTM 3 5 6  2 16
Bronchopneumonia 1 11 7 1 20
COP 1 3 6 0 10
ABPA 1 2 4  0 7
Sarcoidosis 3 2 5  1 11
Lung cancer 1 2 1  0 4
Lymphoma 1 3 1  0 5
Panbronchiolitis 3 2 4  0 9
Septic emboli 1 4 3  0 8
Total 15 40 51 44 150
Table 6. The final diagnosis of the suspected sputum smear-negative PTB on MD-HRCT criteria.
NTM – nontuberculous mycobacterium; COP – cryptognic organizing pneumonia; ABPA – allergic bronchopulmonary aspergillosis.
Rank I Rank II Rank III
Sensitivity 95% 85% 45%
Specificity 40% 72% 90%
Positive likelihood ratio 1.4 3 11.5
Negative likelihood ratio 0 0.3 0.5
Table 7.  Sensitivity, specificity, positive and negative likelihood ratios for each rank of MD-HRCT diagnosis of sputum culture proved pulmonary TB cases.
The lung lobe Number of cases (%)
Right upper lobe  90 (60%)
Left upper lobe  30 (20%)
Right lower lobe  15 (10%)
Left lower lobe  10 (6.67%)
Right middle lobe  5 (3.33%)
Table 5. The lobar distribution of the lesions.
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cause an important medical problem in daily medical prac-
tice that is difficult to analyze [8].
Clinicians have some difficulties about whether anti-
tuberculous therapy should be initiated for these patients. 
Prompt initiation of anti-tuberculous therapy for pulmo-
nary TB is an important issue both because of its benefits 
for the patient and for control of the disease [9].
It may not be appropriate to use the same criteria for cases 
of both smear-positive and smear-negative pulmonary TB 
to predict the risk in the latter group patients since smear-
negative patients have lower mycobacterium burden [10].
In our study, we combined the clinical features together 
with the HRCT findings to differentiate smear-negative and 
culture- negative PTB from smear-negative and culture- 
positive disease. Cough was the most common symptom 
reported (90% of the cases). Nakashi et al., [3] also reported 
that cough was seen in 83% of patients as the most com-
mon symptom in smear-negative PTB [3]. This was on the 
contrary of a study developed to validate a clinical-radio-
logical score to assess the probability of pulmonary TB in 
patients suspected of smear negative pulmonary TB, pro-
ductive cough was less frequent in smear negative pul-
monary TB patients [11]. This was in agreement with a 
multivariate model, having no cough and no radiographic 
pattern typical of TB were the characteristics associated 
with a diagnosis of smear negative pulmonary TB [12].
Chest pain is the second presenting complaint, related to 
pleural involvement and considered a symptom for PTB. 
Tozkoparan et al., reported chest pain is the most com-
mon symptom (38%) for smear negative PTB and confirmed 
the high existence of chest pain in active smear-negative 
PTB [10].
Other related symptoms in our patients were expectora-
tion, hemoptysis, fever and weight loss. Our results showed 
that smear-negative culture-positive PTB cannot be dis-
criminated from smear-negative and culture-negative PTB 
based on clinical symptoms and laboratory parameters. 
The presence of a dry cough, a high respiratory rate, a low 
eosinophil count, a mixed type of anemia and presence of 
a cavity were found to be predictive of smear negative but 
culture positive PTB [13].
The value of CT chest in diagnosing pulmonary TB 
was studied by many authors: Lee KS and colleagues in 
1996 [14] studied the utility of CT in the evaluation of TB 
among patients without AIDS, they succeeded to predict 
presence of TB in 133 out of 146 patients proved to have 
Figure 1.  (A, B) Axial MD HRCT (pulmonary window) showing centrilobular nodules with tree in bud configuration, consolidated area with air 
bronchogram and cavity formation in the right upper lobe anterior segment in a 21 years old male complaining of low grade fever, cough 
and expectoration.
A B
Figure 2.  (A, B) Axial MD HRCT (pulmonary window) showing localized bronchiectatic changes with centrilobular nodules arranged in tree in bud 
configuration in the apical segment of the right lower lobe associated with centrilobular nodules arranged in tree in bud configuration in 
the inferior segment of the lingua in a 45 years old male complaining of cough, expectoration and weight loss.
A B
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Figure 3.  Sagittal (A) and coronal (B) MD HRCT (pulmonary window) showing right upper lobar consolidated area with air bronchogram associated 
with right upper lobar centrilobular nodules arranged in tree in bud configuration associated with localized bronchiectatic changes in the 
apical segment of the right upper lobe as well as the apical segment of the right lower lobe in a 30 years old male complaining of cough, 
chest pain and hemoptysis.
A B
Figure 4.  (A, B) Coronal MD HRCT (mediastinal window) showing right sided lamellar pleural effusion and consolidated area with air bronchogram 
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Figure 5.  Axial (A, B), Sagittal (C, D) and coronal (E, F) MD HRCT (pulmonary window) showing large anterior air filled cavity occupying most of the 
right upper lobe extending from the lung apex down to the right diaphragmatic copula associated with two thickened wall cavities, each 
harboring solid content (mycetoma formation) at the apical segment of the right lower lobe with air crescent sign in a 62 years old male 
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TB and to exclude TB in 32 out of 42 patients proved to 
have other diseases, they concluded that CT can be helpful 
in the diagnosis of pulmonary tuberculosis in most cases. 
On the basis of CT findings, distinction of active from inac-
tive disease can be made in most cases. Lee SW and col-
leagues in 2010 [15] studied the use of CT in investigation 
of TB out break and with the use of CT they could diagnose 
active TB in nine patients who had normal chest X-ray and 
they concluded that adding CT to routine investigation of 
TB outbreak may be helpful in differentiating active TB 
from Latent TB infection.
HRCT findings in patients with active pulmonary TB 
include; micronodules, tree in bud appearance, airspace con-
solidation, nodules, ground glass opacities and cavities [16].
Matsuoka et al., [17] investigate the relationship between 
computed tomography (CT) findings in patients with active 
pulmonary tuberculosis (PTB) and number of the acid-fast-
bacilli (AFB) on sputum smears and they found that the fre-
quency of micronodules and nodules did not significantly 
differ among the smear positive and smear negative groups. 
In contrast, the frequency of consolidation and cavitation 
increased with the number of AFB. In another study by 
Kosaka and his colleagues in 2005 [6] they found that air 
space consolidation, cavitation and ground glass opacities 
occurred significantly more frequently in the smear posi-
tive than in the smear negative active PTB patients while 
the frequency of centrilobular nodules (micronodules) did 
not differ between the two groups.
Tozkoparan et al., [10] found that HRCT had good diagnos-
tic value in detecting activity of smear negative pulmonary 
tuberculosis. In their series the sensitivity, specificity, posi-
tive predictive value and accuracy of HRCT in detecting 
disease activity were 88%, 88%, 92% and 88%, respectively. 
On the other hand in the study of Lee et al., [16] the sen-
sitivity, specificity, positive predictive value and positive 
likelihood ratio of HRCT in the diagnosis of smear nega-
tive pulmonary tuberculosis were 80%, 70%, 71% and 2.71. 
They concluded that HRCT alone had relatively good sen-
sitivity but the low positive predictive value hampered 
the decision of starting anti-TB medication. However in 
the previous two studies, the HRCT diagnosis of active 
pulmonary TB was by consensus. Nakanishi and his col-
leagues in 2010 [3] investigated whether or not HRCT can 
predict risk for sputum smear-negative pulmonary TB. 
They ranked the patients from 1 to 3 based on a mixture of 
the HRCT findings that were significantly correlated with 
increased risk of pulmonary TB. Those comprised; large 
nodules, tree in bud appearance, lobular consolidation and 
presence of main lesion in S1, S2 and S6 segments). They 
found that this ranking was reliable enough to predict 
the risk of pulmonary TB with good reproducibility. Their 
results included the following: Rank 3 had sensitivity, spec-
ificity and positive likelihood ratio of 40%, 97% and 13.3 
while rank 2 had 85%, 74% and 3.27 as sensitivity, specific-
ity and positive likelihood ratio respectively. These results 
are confirmed by the results of our study. In this study the 
sensitivity, specificity and positive likelihood ratio of rank 
3 were 45%, 90% and 11.5 respectively while rank 2 the 
results were 85%, 72% and 3 respectively. Our results are 
also keeping with the study done by Shaarrawy et al. [4] 
where the sensitivity, specificity and positive likelihood 
ratio of rank 3 were 48%, 91% and 12.5 respectively and 
in rank 2 there results were 79%, 70% and 3.1 respectively
The main role of HRCT for diagnosing pulmonary TB is the 
selection of probable or highly suspected pulmonary TB 
with pulmonary infiltrates of unknown origin and with 
negative sputum smears [3].
In the present study 12 out of the 51 ranked at HRCT as 
rank II and 40 out of the 44 rank III patients had final diag-
nosis of active pulmonary TB.
Conclusions
To conclude, for prediction of high risk patients among 
those with suspicion of having active pulmonary TB whose 
sputum smears are negative, HRCT findings are more or 
less of great value. Beside that, these findings can be 
applied to choose candidate patients for further laboratory 
tests or bronchoscopy.
Conflict of interest
The authors declared no conflict of interest.
 1. Caliskan T, Ozkisa T, Aribal S et al: High resolution computed 
tomography findings in smear-negative pulmonary tuberculosis 
patients according to their culture status. J Thorac Dis, 2014; 6(6): 
706–12
 2. Global Tuberculosis Report, WHO (2012): Available online: http://
www.who.int/tb/publications/global_report/gtbr12_main.pdf
 3. Nakanishi M, Demura Y, Ameshima S et al: Utility of high-resolution 
computed tomography for predicting risk of sputum smear-negative 
pulmonary tuberculosis. Eur J Radiol, 2010; 73: 545–50
 4. Shaarrawy H, Zeidan M, Nasr A et al: Assessment of the role of 
high resolution computed tomography in the diagnosis of suspected 
sputum smear negative active pulmonary TB. Egypt J Chest Dis 
Tuberc, 2013; 62: 263–68
 5.  Lee HM, Shin JW, Kim JY et al: HRCT and whole-blood Interferon-g 
assay for the rapid diagnosis of smear negative pulmonary 
tuberculosis. Respiration, 2010; 79: 454–60
References:
 6. Kosaka N, Sakai T, Uematsu H et al: Specific high resolution 
computed tomography findings associated with sputum smear 
positive pulmonary tuberculosis. J Comput Assist Tomogr, 2005; 29: 
801–4
 7. Yeh JJ, Yu JK, Teng WB et al: High-resolution CT for indentify 
patients with smear positive active pulmonary tuberculosis. Eur J 
Radiol, 2012; 81: 195–201
 8. Mello FC, Bastos LG, Soares SL et al: Predicting smear negative 
pulmonary tuberculosis with classification trees and logistic 
regression: A cross-sectional study. BMC Public Health, 2006; 6: 43
 9. Affolabi D, Akpona R, Odoun M et al: Smear-negative, culturepositive 
pulmonary tuberculosis among patients with chronic cough in 
Cotonou, Benin. Int J Tuberc Lung Dis, 2011; 15: 67–70
 10. Tozkoparan E, Deniz O, Ciftci F et al: The roles of HRCT and clinical 
parameters in assessing activity of suspected smear negative 
pulmonary tuberculosis. Arch Med Res, 2005; 36: 166–70
 11. Soto A, Solari L, Diaz J et al: Validation of a clinical-radiographic 
score to assess the probability of pulmonary tuberculosis in suspect 
patients with negative sputum smears. PLoS One, 2011; 6(4): e18486
Review Article
815
© Pol J Radiol, 2017; 82: 808-816
 12. Campos LC, Vieira Rocha MV, Cunha Willers DM et al: Characteristics 
of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a 
Region with High TB and HIV Prevalence. PLoS One, 2016; 11(1): 
e0147933
 13. Swai1 HF, Mugusi FM, Mbwambo JK: Sputum smear negative 
pulmonary tuberculosis: sensitivity and specificity of diagnostic 
algorithm. 2011; http://www.biomedcentral.com/1756-0500/4/475
 14. Lee KS, Hwang JW, Chung MP et al: Utility of CT in the evaluation of 
pulmonary tuberculosis in patients without AIDS. Chest, 1996; 110: 
977–84
 15. Lee SW, Jang YS, Park CM et al: The role of chest CT scanning in TB 
outbreak investigation. Chest, 2010; 137(5): 1057–64
 16. Lee JJ, Chong PY, Lin CB et al: High resolution CT in patients with 
pulmonary tuberculosis: characteristic findings before and after 
antituberculous therapy. Eur J Radiol, 2008; 67: 100–4
 17. Matsuoka S, Uchiyama K, Shima H et al: Relationship between CT 
findings of pulmonary tuberculosis and the number of acid-fast 
bacilli on sputum smears. Clin Imaging, 2004; 28: 119–23
Alsowey A. et al. – MD-HRCT in suspected sputum smear – ve active PTB
816
© Pol J Radiol, 2017; 82: 808-816
